Israel’s Arkin Holdings raises $140M for second life sciences investment fund
The company, based near Tel Aviv, said it plans to invest money from the fund, Arkin Bio-Ventures II, in areas like gene therapy, as well as RNA- and DNA-targeted drugs.
Herzliya Pituach